CRISPR-Cas systems are an adaptive prokaryotic defense mechanism set against viral infection and horizontal gene transfer. The sequence-specific degradation of invasive nucleic acids (NA) is carried out by ribonucleoprotein effector complexes. While the cleavage is executed by protein subunits, the recognition of specific target nucleic acid is performed mostly by an RNA molecule called crRNA. This feature allows easy programmability of sequence-specificity of the CRISPR-Cas systems. Effector complexes from Type I and II CRISPR-Cas systems (Cascade and Cas9-RNA, respectively) cleave foreign DNA [1]. Currently they are being developed into precise genome editing tools [2]. On the other hand, Type III-B effector complexes degrade RNA [3]. However, genetic evidence suggested that closely related Type III-A Csm complex targets DNA [4]. Recently DNA cleavage by Csm complex has been reconstituted in vitro, although in a complex system involving transcription [5]. Nevertheless, the mechanism nucleic acid interference, mediated by Csm complexes, remains unclear.
Here we aimed to establish the nucleic acid specificity and cleavage mechanism of the Type III-A system Csm-machinery using Streptococcus thermophilus as a model system. We expressed the Type III-A CRISPR-Cas locus in Escherichia coli, isolated the Csm effector complex and characterized its composition. We showed that Csm complex recognizes target RNA molecules via basepairing with crRNA and Csm3 proteins, present in the Csm complexes in several copies, cleaves them in multiple sites interspaced by 6 nucleotides [6]. Moreover, we discovered that target RNA binding promotes single-stranded DNA hydrolysis by the Csm complex and identified the active center responsible for this activity. We also established that host cell protects its own DNA from degradation both by means of spatiotemporal regulation of Csm complex activity and by recognition of its own transcripts via the sequences flanking the target. Further, we demonstrated that Csm complex may be reprogrammed to cleave the NA substrate of interest in vitro and in vivo (in E. coli cells). This opens new possibilities for a programmable precise RNA cleaving tool as well as cell selection in molecular biology.